TEKMIRA PHARMACEUTICALS Corp | 2013 | FY | 3


   
Common shares
purchasable upon
exercise of
warrants
   
Weighted average
exercise price (C$)
   
Weighted
average exercise
price (US$)
   
Range of
exercise prices
(C$)
   
Range of
exercise prices
(US$)
   
Weighted
average
remaining
contractual life
(years)
   
Aggregate
intrinsic value
(C$)
   
Aggregate
intrinsic value
(US$)
 
                                                         
Balance, December 31, 2011
    949,495     $ 3.25     $ 3.20     $1.65 - $3.35     $1.62 - $3.29       4.6     $ -     $ -  
Issued
    924,302     $ 2.60     $ 2.61       $2.60         $2.61                            
Exercised
    (285,386 )   $ 2.53     $ 2.54     $1.65 - $3.35     $1.66 - $3.37                          
Balance, December 31, 2012
    1,588,411     $ 3.00     $ 3.02     $2.50 - $3.35     $2.51 - $3.37       3.8       3,140,893       3,156,912  
Issued
    -       -       -       -         -                            
Exercised
    (573,683 )   $ 3.19     $ 3.00     $2.60 - $3.35     $2.44 - $3.15                       -  
Balance, December 31, 2013
    1,014,728     $ 2.90     $ 2.72     $2.60 - $3.35     $2.44 - $3.15       2.7     $ 5,635,446     $ 5,298,447  

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock